Literature DB >> 1444269

The lipophosphoglycan of Leishmania parasites.

S J Turco1, A Descoteaux.   

Abstract

Protozoan parasites of the genus Leishmania have the remarkable ability to avoid destruction in the hostile environments they encounter throughout their life cycle. The molecular details of how these pathogens persevere with impunity under harsh conditions are beginning to be understood. The fact that Leishmania parasites have adapted to not only survive, but to proliferate probably is due to the protection conferred by specialized molecules on the parasite's cell surface. One such macromolecule is a novel glycoconjugate called lipophosphoglycan. This heterogeneous, lipid-containing polysaccharide is the major surface molecule of the parasite and has been implicated in a surprisingly large number of functions that may contribute the the parasite's pathogenesis. This review emphasizes the structural aspects of lipophosphoglycan and its possible functions and biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444269     DOI: 10.1146/annurev.mi.46.100192.000433

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  122 in total

1.  Proteophosphoglycans of Leishmania mexicana. Molecular cloning and characterization of the Leishmania mexicana ppg2 gene encoding the proteophosphoglycans aPPG and pPPG2 that are secreted by amastigotes and promastigotes.

Authors:  U Göpfert; N Goehring; C Klein; T Ilg
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

2.  Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: modulation of gp63 level in promastigotes and their infection of macrophages in vitro.

Authors:  D Q Chen; B K Kolli; N Yadava; H G Lu; A Gilman-Sachs; D A Peterson; K P Chang
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

3.  Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle.

Authors:  N Genois; B Barbeau; M Olivier; M J Tremblay
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

4.  AuBr(3) mediated glycosidations: synthesis of tetrasaccharide motif of the Leishmania donovani lipophosphoglycan.

Authors:  Gopalsamy Sureshkumar; Srinivas Hotha
Journal:  Glycoconj J       Date:  2012-06-03       Impact factor: 2.916

5.  Effect of glycosphingolipids purified from Leishmania (Leishmania) amazonensis amastigotes on human peripheral lymphocytes.

Authors:  Selma Giorgio; Marcia Regina M Santos; Anita H Straus; Helio K Takahashi; Clara Lúcia Barbiéri
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

6.  Biosynthesis of lipophosphoglycan from Leishmania major: solubilization and characterization of a (beta 1-3)-galactosyltransferase.

Authors:  K Ng; E Handman; A Bacic
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

7.  Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response.

Authors:  C Kébaïer; H Louzir; M Chenik; A Ben Salah; K Dellagi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

8.  Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators.

Authors:  Sharvan Sehrawat; Amol Suryawanshi; Mitsuomi Hirashima; Barry T Rouse
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani.

Authors:  Joseph L Amprey; Gerald F Späth; Steven A Porcelli
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani.

Authors:  R Bernier; S J Turco; M Olivier; M Tremblay
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.